Risk of Relapse after Anti-PD1 Discontinuation and Efficacy of Anti-PD1 Re-Treatment in Patients with Hodgkin Lymphoma

被引：4
|
作者：
Manson, Guillaume [1 ]
Brice, Pauline [2 ]
Herbaux, Charles [3 ]
Silva, Maria [4 ]
Bouabdallah, Krimo [5 ]
Deau-Fisher, Benedicte [6 ]
Bouteloup, Juliette [7 ]
de Collela, Jean Marc Schiano [8 ]
Nicolas-Virelizier, Emmanuelle [9 ]
Maerevoet, Marie [10 ]
Ghesquieres, Herve [11 ]
Bastard, Aspasia Stamatoulas [12 ]
Antier, Chloe [13 ]
Poizeau, Florence [14 ]
Dercle, Laurent [15 ]
Houot, Roch [16 ]
机构：
[1] Univ Hosp Rennes, Dept Hematol, Rennes, France
[2] Hop St Louis, Dept Hematol, Paris, France
[3] CHRU Lille, Lille, France
[4] Inst Portugues Oncol Lisboa, Dept Hematol, Lisbon, Portugal
[5] Univ Hosp Bordeaux, Dept Hematol, Pessac, France
[6] Cochin Hosp, Dept Hematol, Paris, France
[7] Chalon Ctr Hosp, Dept Hematol, Chalon Sur Saone, Saone & Loire, France
[8] Inst Paoli Calmettes, Marseille, France
[9] Leon Berard Ctr, Dept Hematol, Lyon, France
[10] Hosp Jules Bordet, Brussels, Belgium
[11] Hosp Civils Lyon, Dept Hematol, Ctr Hosp Lyon Sud, Pierre Benite, France
[12] Henri Becquerel Ctr, Rouen, France
[13] Nantes Univ Hosp, Dept Hematol, Nantes, France
[14] Rennes Univ Hosp, Dept Dermatol, Rennes, France
[15] Inst Gustave Roussy, Dept Med Imaging, Villejuif, France
[16] CHU Rennes, Dept Hematol, Rennes, France
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-122171
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1549
引用
收藏
页数：3
相关论文
共 50 条
  • [21] A future boost for anti-PD1 responses
    Hannah Stower
    Nature Medicine, 2020, 26 : 1331 - 1331
  • [22] Local IFNα enhances the anti-tumoral efficacy of systemic anti-PD1 to prevent tumor relapse
    Guerin, Marion, V
    Regnier, Fabienne
    Thoreau, Maxime
    Vimeux, Lene
    Benard, Matthieu
    Dransart, Estelle
    Penny, Hweixian L.
    Johannes, Ludger
    Trautmann, Alain
    Bercovici, Nadege
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [23] Anti-PD1 antibodies in the adjuvant setting
    Dreno, B.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 : 14 - 14
  • [24] Biomarkers of Anti-PD1 Therapy in Mesothelioma
    Baas, P.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S181 - S182
  • [25] Anti-PD1/PDL1 IgG subclass distribution in ten cancer types and anti-PD1 IgG4 as biomarker for the long time survival in NSCLC with anti-PD1 therapy
    Qiaoyun Tan
    Liyuan Dai
    Yanrong Wang
    Shuxia Liu
    Te Liang
    Rongrong Luo
    Shasha Wang
    Ning Lou
    Haizhu Chen
    Yu Zhou
    Qiaofeng Zhong
    Jianliang Yang
    Puyuan Xing
    Xingsheng Hu
    Yutao Liu
    Shengyu Zhou
    Jiarui Yao
    Di Wu
    Zhishang Zhang
    Le Tang
    Xiaobo Yu
    Xiaohong Han
    Yuankai Shi
    Cancer Immunology, Immunotherapy, 2022, 71 : 1681 - 1691
  • [26] The impact of corticosteroid use during anti-PD1 treatment
    Pan, Eva Y.
    Merl, Man Yee
    Lin, Katherine
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (04) : 814 - 822
  • [27] Brentuximab vedotin and anti-PD1 blockade optimize survival in chemo-refractory hodgkin lymphoma patients
    Sakellari, Ioanna
    Boussiou, Zoi
    Gavriilaki, Eleni
    Chatziioannidis, Aris
    Batsis, Ioannis
    Mallouri, Despina
    Constantinou, Varnavas
    Iskas, Michail
    Stavroyianni, Niki
    Syrigou, Antonia
    Marvaki, Anastasia
    Pilavaki, Maya
    Papaemmanuil, Styliani
    Anagnostopoulos, Achilles
    BONE MARROW TRANSPLANTATION, 2019, 54 : 467 - 467
  • [28] Anti-PD1/PDL1 IgG subclass distribution in ten cancer types and anti-PD1 IgG4 as biomarker for the long time survival in NSCLC with anti-PD1 therapy
    Tan, Qiaoyun
    Dai, Liyuan
    Wang, Yanrong
    Liu, Shuxia
    Liang, Te
    Luo, Rongrong
    Wang, Shasha
    Lou, Ning
    Chen, Haizhu
    Zhou, Yu
    Zhong, Qiaofeng
    Yang, Jianliang
    Xing, Puyuan
    Hu, Xingsheng
    Liu, Yutao
    Zhou, Shengyu
    Yao, Jiarui
    Wu, Di
    Zhang, Zhishang
    Tang, Le
    Yu, Xiaobo
    Han, Xiaohong
    Shi, Yuankai
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (07) : 1681 - 1691
  • [29] Anti-PD1 treatment in metastatic uveal melanoma in the Netherlands
    van der Kooij, M. K.
    Joosse, A.
    Speetjens, F. M.
    Hospers, G. A. P.
    Bisschop, C.
    de Groot, J. W. B.
    Koornstra, R.
    Blank, C. U.
    Kapiteijn, E.
    ACTA ONCOLOGICA, 2017, 56 (01) : 101 - 103
  • [30] Anti-PD1 antibody: a new approach to treatment of lymphomas
    Bachy, Emmanuel
    Coiffier, Bertrand
    LANCET ONCOLOGY, 2014, 15 (01): : 7 - 8
12345